Pulmonary-Allergy Drugs Advisory Committee Meeting

Pulmonary-Allergy Drugs Advisory Committee Meeting Committee Meeting January 30, 2013 8:00 a.m. to 4:00 p.m. (Day 2 of 2) Agenda: The committee will discuss the new drug application (NDA) 202049, for mannitol inhalation powder (proposed trade name BRONCHITOL), for oral inhalation sponsored by Pharmaxis, for the proposed indication of management of cystic fibrosis (CF) in patients aged 6 years and older to improve pulmonary function.